| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | EVP & Chief Business Officer, Director | Common Stock | 68,464 | $15,610 | $0.2280 | 01 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 01 Jan 2025 | 2 | $0 | 4 | EVP & Chief Business Officer, Director | 03 Jan 2025, 17:34 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 11 Mar 2024 | 1 | $0 | 4 | EVP & Chief Business Officer, Director | 13 Mar 2024, 20:56 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 15 Dec 2021 | 1 | $0 | 4 | Director | 17 Dec 2021, 16:01 |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | 10 Dec 2021 | 1 | $0 | 4 | Director | 10 Dec 2021, 19:01 |